Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

NCT02187627 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease, Healthy Volunteer

Interventions

DRUG: [11C]RO6924963
DRUG: [11C]RO6931643
DRUG: [18F]RO6958948

Sponsor

Hoffmann-La Roche